{"id":"W4231118242","doi":"10.1093/ecco-jcc/jjx180.643","title":"P516 Efficacy and safety of tofacitinib retreatment for ulcerative colitis after treatment interruption: Results from the OCTAVE clinical trials","year":2018,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Tofacitinib; Octave (electronics); Ulcerative colitis; Maintenance therapy; Clinical trial; Open label; Surgery; Internal medicine; Chemotherapy; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004585561,0.000661513,0.00196321,0.0003829216,0.0004183677,0.001350233,0.0006879501,0.001635312,0.004092891],"category_scores_gemma":[0.006608258,0.0002667143,0.002819521,0.0006742921,0.0006942145,0.001493928,0.0003770987,0.002645266,0.000958837],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005724049,"about_ca_system_score_gemma":0.000637296,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000379866,"about_ca_topic_score_gemma":0.001226859,"domain_scores_codex":[0.9976954,0.001123833,0.0002766598,0.0002853222,0.0003928345,0.000225935],"domain_scores_gemma":[0.9960218,0.001632836,0.001246441,0.0003127936,0.0003486637,0.0004374524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5208977,0.007586377,0.0247756,0.005597494,0.008097898,0.0004619465,0.0003939642,0.003203245,0.01988746,0.0008251632,0.01128743,0.3969858],"study_design_scores_gemma":[0.386865,0.3819116,0.1637512,0.001225967,0.01011363,0.002795287,0.0002554334,0.004219733,0.007135302,0.00215736,0.03936458,0.000204887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9258936,0.05036959,0.001494253,0.001953461,0.0002921448,0.001586221,0.004228426,0.0001622129,0.01402009],"genre_scores_gemma":[0.9776424,0.01126102,0.001168795,0.001764492,0.000402728,0.0008967667,0.004816802,0.00003488738,0.002012028],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004585561,"threshold_uncertainty_score":0.02425104,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1265778337322519,"score_gpt":0.4222906470315133,"score_spread":0.2957128132992615,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}